Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...

Pfizer (NYSE:PFE) has reduced its ownership in the British consumer healthcare giant Haleon (NYSE:HLN) to 15% from 22.6% by selling £2.45B ($3.26B) worth of company shares, Reuters reported ...

Is it true that the higher the dividend yield, the riskier the dividend? Not always. Some companies with exceptionally high ...

Pfizer Inc. (PFE) has sold its stake worth $3.26 billion in UK-based consumer healthcare company Haleon PLC (GB:HLN). With this transaction, Pfizer’s ownership in Haleon has been reduced to 15% ...

Pfizer Inc. is poised to raise about £2.7 billion ($3.6 billion) from the sale of Haleon Plc shares, as it further reduces its stake in the UK consumer health giant. The US company increased the ...

(Bloomberg) -- Pfizer Inc. has raised about £2.4 billion ($3.2 billion) from the sale of Haleon Plc shares, as it further reduces its stake in the UK consumer health company. The US ...

(Alliance News) - Pfizer Inc sold a 7.6% stake in consumer health products firm Haleon PLC for GBP2.7 billion, the investment banks running the offer confirmed on Tuesday. Pfizer, a New York-based ...

Pfizer, which is under pressure from activist investor Starboard, on Tuesday (Oct 29) topped third-quarter estimates as sales of its Covid-19 treatment Paxlovid blew past Wall Street expectations.

During the same period, the company received roughly $6.9 billion of net cash proceeds from the sale of its shares of Haleon, a consumer health joint venture with GSK. In Pfizer's Q3 earnings call ...

Pfizer Inc sold a 7.6% stake in consumer health products firm Haleon PLC for GBP2.7 billion, the investment banks run ... Subscribe now to see this Premium News article from Alliance News ...